Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMCOVID
DRKS00031463Phase 3Terminated
- Sponsor
- tiakis Biotech AG
- Start
- Mar 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Tiprelestat with Placebo (2 arms). Started Mar 2023; status: terminated.
02
Drugs
tiprelestat
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on DRKS00031463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00031463.